Serum Lipopolysaccharide (LPS) Measurement to Predict Progression of Fibrosis in Liver Transplant Recipients with Hepatitis C Virus
Serum Lipopolysaccharide (LPS) Measurement to Predict Progression of Fibrosis in Liver Transplant Recipients with Hepatitis C Virus.
Are you Eligible? (Inclusion Criteria)
Patients who are either listed for liver transplant or underwent liver transplant for HCV-related cirrhosis.
Specialty Area(s)
Liver
Transplant
Trial Location
NYP/Columbia
New York, NY 10032
United States